Toggle Offcanvas
...
 
Immunosuppressive Agents Tenders

Immunosuppressive Agents Tenders

View immunosuppressive agents tenders, RFPs and contracts. Bid on readily available immunosuppressive agents tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for immunosuppressive agents tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of immunosuppressive agents.

Global Tenders stands out as the largest platform dedicated to tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth immunosuppressive agents market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited immunosuppressive agents tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

18 Live Notices for Immunosuppressive Agents Tenders

Showing 1 to 18

Ozanimod-Containing Medicinal Products
country Czech Republic
posting date21 Jan 2025
deadline24 Feb 2025
Medicinal Products Containing Mycophenolate Mofetil
country Czech Republic
posting date20 Jan 2025
deadline18 Feb 2025
Lp Containing Mycophenolic Acid 2024
country Czech Republic
posting date20 Jan 2025
deadline21 Feb 2025
Selective Immunosuppressants - Ustekinumab Iv.
country Czech Republic
posting date18 Jan 2025
deadline25 Feb 2025
Selective Immunosuppressants - Ustekinumab Iv.
country Czech Republic
posting date15 Jan 2025
deadline25 Feb 2025
Selective Immunosuppressants - Ustekinumab Iv.
country Czech Republic
posting date10 Jan 2025
deadline11 Feb 2025
Delivery Of Medicinal Products And Medical Devices To The Military Institute Of Medicine – National Research Institute
country Poland
posting date09 Jan 2025
deadline20 Feb 2025
Medicinal Products Containing Cyclosporine
country Czech Republic
posting date06 Jan 2025
deadline05 Feb 2025
PROVISION OF ANTITHYMOCYTE IMMUNOGLOBULIN (ATG) INJ&APIXABAN TABLET 5MG&FOSFOMYCIN ORAL GRANULES 3 GRAM&FLUDARABINE PHOSPHATE INJ 50 MG/VIAL&PEGFILGRASTIM 10 MG/ ML 0.6 ML PREFILLED SYRINGE [NEULASTIM]
country Oman
posting date30 Dec 2024
deadline27 Jan 2025
PROVISION OF TOCILIZUMAB INJECTION 200 MG / 10 ML VIAL&RISANKIZUMAB 75MG INJ&IBUPROFEN TABLET 200 MG
country Oman
posting date30 Dec 2024
deadline27 Jan 2025
Environmentally Friendly Supply Of Biological Human Medicines With Biosimilars For Public Health Centres In Valencia
country Spain
posting date30 Dec 2024
deadline01 Oct 2025
Environmentally Friendly Supply Of Biological Human Medicines With Biosimilars For Public Health Centres In Valencia
country Spain
posting date30 Dec 2024
deadline01 Oct 2025
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Abatacept (Atc Code: L04Aa24).
country Germany
posting date10 Nov 2023
deadline27 Oct 2025
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Certolizumab Pegol (Atc Code: L04Ab05).
country Germany
posting date22 Sep 2023
deadline27 Aug 2025
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Tocilizumab (Atc Code: L04Ac07).
country Germany
posting date22 Sep 2023
deadline27 Aug 2025
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products With The Active Ingredient Fingolimod (Atc Code: L04Aa27).
country Germany
posting date14 Aug 2023
deadline28 Jul 2025
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With § 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Infliximab (Atc Code: L04Ab02).
country Germany
posting date09 Jun 2023
deadline27 May 2025
The Medicine Ravulizumab
country Lithuania
posting date15 Oct 2024
deadline15 Oct 2025

Share Share this page